HomeCompareGFKRF vs MRK

GFKRF vs MRK: Dividend Comparison 2026

GFKRF yields 5000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GFKRF wins by $62217131802825.30M in total portfolio value
10 years
GFKRF
GFKRF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full GFKRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GFKRF vs MRK

📍 GFKRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGFKRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GFKRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GFKRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GFKRF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GFKRF beats the other by $50,882,683,244,271,470,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GFKRF + MRK for your $10,000?

GFKRF: 50%MRK: 50%
100% MRK50/50100% GFKRF
Portfolio after 10yr
$31108565901412.70M
Annual income
$29,930,990,143,689,110,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GFKRF
No analyst data
Altman Z
1.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GFKRF buys
0
MRK buys
0
No recent congressional trades found for GFKRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGFKRFMRK
Forward yield5000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$62217131802825.35M$56.8K
Annual income after 10y$59,861,980,287,378,210,000.00$9,798.13
Total dividends collected$62057786341622.61M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GFKRF vs MRK ($10,000, DRIP)

YearGFKRF PortfolioGFKRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$510,700$500,000.00$11,206$366.19+$499.5KGFKRF
2$24,410,935$23,864,485.98$12,650$502.35+$24.40MGFKRF
3$1,092,192,501$1,066,072,800.30$14,407$694.19+$1092.18MGFKRF
4$45,746,366,951$44,577,720,975.17$16,585$967.82+$45746.35MGFKRF
5$1,793,932,828,410$1,744,984,215,772.56$19,342$1,363.89+$1793932.81MGFKRF
6$65,871,973,805,320$63,952,465,678,921.49$22,913$1,947.19+$65871973.78MGFKRF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$27,662$2,823.89+$2265146887.58MGFKRF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$34,159$4,173.35+$72954689148.96MGFKRF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$43,337$6,308.80+$2201076182660.84MGFKRF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$56,776$9,798.13+$62217131802825.30MGFKRF

GFKRF vs MRK: Complete Analysis 2026

GFKRFStock

Opus One Gold Corporation engages in the acquisition, exploration, and evaluation of mineral properties primarily in Canada. It explores for gold and base metals. The company holds 100% interests in the Northern Abitibi project that consists of Vezza Extension, Vezza North, and Bachelor Extension properties located in the Abitibi region of Quebec; and the Courville project situated in Courville Township, Quebec. It has an option to acquire 100% interests in the Noyell property situated in the Northern Abitibi Greenstone Belt, Quebec. The company was formerly known as Opus One Resources Inc. and changed its name to Opus One Gold Corporation in October 2020. Opus One Gold Corporation was incorporated in 1979 and is headquartered in Saint-Lambert, Canada.

Full GFKRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GFKRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GFKRF vs SCHDGFKRF vs JEPIGFKRF vs OGFKRF vs KOGFKRF vs MAINGFKRF vs JNJGFKRF vs ABBVGFKRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.